Rescue of bilirubin‐induced neonatal lethality in a mouse model of Crigler‐Najjar syndrome type I by AAV9‐mediated gene transfer
Rescue of bilirubin‐induced neonatal lethality in a mouse model of Crigler‐Najjar syndrome type I by AAV9‐mediated gene transfer
Crigler-Najjar type I (CNI) syndrome is a recessively inherited disorder characterized by severe unconjugated hyperbilirubinemia caused by uridine diphosphoglucuronosyltransferase 1A1 (UGT1A1) deficiency. The disease is lethal due to bilirubin-induced neurological damage unless phototherapy is applied from birth. However, treatment becomes less effective during growth, and liver transplantation is required. To investigate the pathophysiology of the disease and therapeutic approaches in mice, we generated a mouse model by introducing a premature stop codon in the UGT1a1 gene, which results in an inactive enzyme. Homozygous mutant mice developed severe jaundice soon after birth and died within 11 d, showing significant cerebellar alterations. To rescue neonatal lethality, newborns were injected with a single dose of adeno-associated viral vector 9 (AAV9) expressing the human UGT1A1. Gene therapy treatment completely rescued all AAV-treated mutant mice, accompanied by lower plasma bilirubin levels and normal brain histology and motor coordination. Our mouse model of CNI reproduces genetic and phenotypic features of the human disease. We have shown, for the first time, the full recovery of the lethal effects of neonatal hyperbilirubinemia. We believe that, besides gene-addition-based therapies, our mice could represent a very useful model to develop and test novel technologies based on gene correction by homologous recombination.
Western, Cerebellum, deficiency/genetics, Humans, Mice, Mice, methods, Gene Transfer Techniques, Genetic Vector, genetics, Glucuronosyltransferase, Blotting, Western, Genetic Vectors, blood, Blotting, enzymology/metabolism, Mutation, Reverse Transcriptase Polymerase Chain Reaction, Survival Rate, Mice, Transgenic, enzymology/metabolism/pathology, Crigler-Najjar Syndrome, enzymology/genetics/mortality, Dependoviru, Gene Expression Regulation, Enzymologic, Research Communications, Mice, Cerebellum, Northern, Blotting, Animals, Humans, Glucuronosyltransferase, Muscle, Skeletal, Crigler-Najjar Syndrome, Animals, Animal, Enzymologic, Gene Therapy, Gene Transfer Techniques, Bilirubin, Skeletal, Genetic Therapy, Transgenic, Muscle, Dependovirus, Blotting, Northern, classification/genetics, Disease Model, Animal, Gene Expression Regulation, Mice, Inbred C57BL, Disease Models, Animal, Newborn, Bilirubin, Animals, Newborn, Animals, Animals; Newborn, Bilirubin; blood, Blotting; Northern, Blotting; Western, Cerebellum; enzymology/metabolism/pathology, Crigler-Najjar Syndrome; enzymology/genetics/mortality, Dependovirus; classification/genetics, Disease Models; Animal, Gene Expression Regulation; Enzymologic, Gene Therapy; methods, Gene Transfer Techniques, Genetic Vectors; genetics, Glucuronosyltransferase; deficiency/genetics, Humans, Mice, Mice; Inbred C57BL, Mice; Transgenic, Muscle; Skeletal; enzymology/metabolism, Mutation, Reverse Transcriptase Polymerase Chain Reaction, Survival Rate, Inbred C57BL, Mice, Mutation
Western, Cerebellum, deficiency/genetics, Humans, Mice, Mice, methods, Gene Transfer Techniques, Genetic Vector, genetics, Glucuronosyltransferase, Blotting, Western, Genetic Vectors, blood, Blotting, enzymology/metabolism, Mutation, Reverse Transcriptase Polymerase Chain Reaction, Survival Rate, Mice, Transgenic, enzymology/metabolism/pathology, Crigler-Najjar Syndrome, enzymology/genetics/mortality, Dependoviru, Gene Expression Regulation, Enzymologic, Research Communications, Mice, Cerebellum, Northern, Blotting, Animals, Humans, Glucuronosyltransferase, Muscle, Skeletal, Crigler-Najjar Syndrome, Animals, Animal, Enzymologic, Gene Therapy, Gene Transfer Techniques, Bilirubin, Skeletal, Genetic Therapy, Transgenic, Muscle, Dependovirus, Blotting, Northern, classification/genetics, Disease Model, Animal, Gene Expression Regulation, Mice, Inbred C57BL, Disease Models, Animal, Newborn, Bilirubin, Animals, Newborn, Animals, Animals; Newborn, Bilirubin; blood, Blotting; Northern, Blotting; Western, Cerebellum; enzymology/metabolism/pathology, Crigler-Najjar Syndrome; enzymology/genetics/mortality, Dependovirus; classification/genetics, Disease Models; Animal, Gene Expression Regulation; Enzymologic, Gene Therapy; methods, Gene Transfer Techniques, Genetic Vectors; genetics, Glucuronosyltransferase; deficiency/genetics, Humans, Mice, Mice; Inbred C57BL, Mice; Transgenic, Muscle; Skeletal; enzymology/metabolism, Mutation, Reverse Transcriptase Polymerase Chain Reaction, Survival Rate, Inbred C57BL, Mice, Mutation
2 Research products, page 1 of 1
- 2017IsRelatedTo
- 2017IsRelatedTo
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).71 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
